Astrana Health, Inc. logo ASTH - Astrana Health, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $41.17 DETAILS
HIGH: $47.00
LOW: $37.00
MEDIAN: $40.50
CONSENSUS: $41.17
UPSIDE: 8.77%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2015
Revenue
Revenue 3,181.8 2,034.5 1,386.7 1,144.2 773.9 370.2 560.6 519.9 357.7 44.0
Cost of Revenue 2,886.0 1,763.2 1,171.7 944.7 596.1 348.5 467.8 380.4 293.7 34.4
Gross Profit 295.8 271.4 215.0 199.5 177.8 21.7 92.8 139.5 64.0 9.7
Operating Expenses
R&D Expenses 0 0 0 0 0 0 0 0 0 0
SG&A Expenses 217.3 154.1 112.6 77.7 62.1 15.6 41.5 47.2 26.4 16.3
Other Expenses 0 27.9 17.7 17.5 17.5 0.0 18.9 0 0 0
Operating Expenses 217.3 182.0 130.3 95.2 79.6 15.6 60.4 47.2 26.4 16.3
Operating Income
Operating Income 78.5 89.3 84.6 104.3 98.2 6.1 32.4 92.2 37.6 (6.6)
Interest Expense 49.9 33.1 16.1 7.9 5.4 2.5 4.7 0.6 0.1 0.5
Interest Income 12.2 14.5 14.2 2.0 1.6 0.4 2.0 1.3 1.0 0
Profitability
EBITDA 124.3 141.8 123.7 112.1 100.7 29.7 48.9 102.5 68.9 (7.4)
EBIT 78.5 113.9 105.9 94.5 83.1 11.4 30.6 83.2 49.8 (7.7)
Income Before Tax 39.6 80.8 89.8 86.6 77.7 8.9 25.8 82.6 49.7 (8.2)
Income Tax Expense 15.5 30.9 32.0 40.9 31.7 9.2 8.2 22.4 3.9 (0.1)
Net Income 22.5 43.1 60.7 45.2 68.9 (23.8) 14.1 10.8 25.8 (9.3)
Per Share Data
EPS (Basic) 0.46 0.91 1.30 1.00 1.57 1.04 0.41 0.33 1.01
EPS (Diluted) 0.46 0.90 1.29 0.99 1.52 1.01 0.39 0.29 0.90 -1.79
Shares Outstanding 49.1 47.7 46.7 45.0 43.8 36.5 34.7 32.9 25.5 0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2015
Current Assets
Cash & Cash Equivalents 429.5 288.5 293.8 288.0 233.1 193.5 103.2 106.9 119.8 9.3
Short-Term Investments 0 2.4 2.5 5.6 53.4 67.7 116.5 1.1 1.1 0
Net Receivables 407.6 324.8 147.8 119.7 99.3 60.6 99.0 57.5 20.1 4.0
Inventory 0 0 0 0 0 0 0 0 0 0
Other Current Assets 26.3 22.9 17.4 14.8 0 0 0.1 0 0 0
Total Current Assets 863.3 638.5 461.5 428.1 404.5 338.6 329.1 172.9 144.2 13.6
Non-Current Assets
Property, Plant & Equipment 94.4 46.9 44.6 129.0 68.6 48.5 26.4 12.7 13.8 1.2
Goodwill 863.9 419.3 278.8 269.1 246.4 239.1 238.5 185.8 189.8 1.6
Intangible Assets 271.0 118.2 71.6 76.9 82.8 87.0 103.0 0 0 0
Long-Term Investments 25.6 48.2 32.2 42.7 42.6 80.4 29.3 53.5 37.6 0.5
Other Non-Current Assets 100.4 63.2 2.2 4.6 22.4 19.4 2.4 1.2 1.6 0.3
Total Non-Current Assets 1,355.3 716.4 471.9 538.1 462.9 478.9 399.6 340.1 346.5 6.0
Total Assets 2,218.7 1,354.9 933.4 966.2 867.4 817.5 728.7 513.0 490.6 19.6
Current Liabilities
Account Payables 3.5 15.2 9.1 10.5 5.5 9.6 6.9 4.5 27.2 2.0
Short-Term Debt 55.7 9.4 19.5 0.6 0.8 10.9 9.5 0.0 5.5 0.2
Deferred Revenue 0 1.6 0.7 0.5 16.8 13.0 8.9 9.0 0.2 0.1
Other Current Liabilities 556.1 257.7 164.0 113.2 65.9 67.1 62.0 41.8 69.0 2.9
Total Current Liabilities 615.3 365.6 218.7 148.6 114.7 115.0 105.4 72.0 109.6 7.4
Non-Current Liabilities
Long-Term Debt 990.9 425.3 258.9 203.4 182.9 230.2 232.2 13 0 0
Deferred Tax Liabilities 5.5 4.6 4.1 14.2 30.1 11.0 18.3 19.6 24.9 0.0
Other Non-Current Liabilities 17.1 14.0 3.6 20.3 14.8 0 0 1.2 19.3 3.5
Total Non-Current Liabilities 1,045.1 475.1 303.9 259.1 242 257.3 262.2 34.3 44.7 3.6
Total Liabilities 1,660.3 840.7 522.6 407.7 356.7 372.3 367.7 106.3 154.3 11.0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings 308.4 286.3 243.1 182.4 137.2 69.8 31.9 17.8 1.7 (28.7)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 (0.0)
Total Stockholders' Equity 779.3 712.7 614.2 542.6 448.2 330.8 191.5 180.5 159.9 5.8
Total Liabilities & Equity 2,218.7 1,354.9 933.4 966.2 867.4 817.5 728.7 513.0 490.6 19.6
Debt Metrics
Total Debt 1,078.1 471.8 321.0 229.4 201.0 260.6 256.6 13.7 6.3 0.2
Net Debt 648.7 183.4 27.2 (58.7) (32.1) 67.1 153.4 (93.2) (113.5) (9.1)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2015
Operating Activities
Net Income 24.1 49.9 57.8 45.7 46.1 122.1 17.7 10.8 25.8 (9.3)
Depreciation & Amortization 45.7 27.9 17.7 17.5 17.5 18.4 18.3 19.3 19.1 0.4
Stock-Based Compensation 38.6 34.5 22.0 16.1 6.7 3.4 1.5 0 0 0
Change in Working Capital (3.1) (63.6) (23.4) (2.0) (33.6) 4.0 (22.8) (63.0) 16.0 2.6
Other Non-Cash Items 13.6 7.7 6.4 19.0 26.0 (102.1) 5.7 157.3 42.1 4.1
Operating Cash Flow 114.6 52.2 68.2 82.1 70.3 46.2 13.7 26.1 53.1 (1.8)
Investing Activities
Capital Expenditure (10.1) (8.0) (28.5) (22.9) (19.2) (1.2) (1.0) (1.2) (2.1) (0.3)
Acquisitions (548.6) (156.1) (7.5) (18.5) (3.9) 31.4 (53.0) (16.7) 0 0.0
Purchases of Investments 0 (2.6) (6.2) (1.9) (28) (1.8) (115.4) (0.4) (18.0) 0
Sales/Maturities of Investments 15.1 0.1 0.5 31.7 67.6 50.6 0 0 0.0 0
Other Investing Activities 4.6 (25.7) (23.8) 4.5 0.1 16.4 (11.2) (7.5) 26.8 0
Investing Cash Flow (539.0) (192.4) (65.5) (7.1) 16.5 95.5 (180.6) (25.8) 6.7 (0.2)
Financing Activities
Net Debt Issuance 604.8 152.7 79.2 (0.8) (58.7) (9.6) 234.5 7.4 4.9 (7.9)
Stock Repurchased (15.4) (0.9) (10.2) (9.2) (5.7) (0.5) (7.6) (5.0) (3.2) 0
Dividends Paid (7.9) (4.0) (62.1) (14.0) (31.1) (51.3) (61.7) (17.8) (10.4) 0
Other Financing Activities (12.1) (12.6) (5.0) 4.0 (1.4) (1.0) (2.6) 0.0 (9) (1.0)
Financing Cash Flow 569.3 135.1 3.4 (20.1) (47.7) (51.7) 163.3 (11.2) (15.0) 6.3
Cash Position
Net Change in Cash 144.9 (5.1) 6.1 54.9 39.1 90.0 (3.6) (12.9) 110.5 4.3
Cash at Beginning 289.1 294.2 288.0 233.1 194.0 104.0 107.6 119.8 9.3 5.0
Cash at End 434.0 289.1 294.2 288.0 233.1 194.0 104.0 106.9 119.8 9.3
Free Cash Flow 104.5 44.2 39.7 59.2 51.1 45.0 12.6 24.9 51.0 (2.1)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2015
Income Statement
Revenue 3,181.8 2,034.5 1,386.7 1,144.2 773.9 370.2 560.6 519.9 357.7 44.0
Gross Profit 295.8 271.4 215.0 199.5 177.8 21.7 92.8 139.5 64.0 9.7
Operating Income 78.5 89.3 84.6 104.3 98.2 6.1 32.4 92.2 37.6 (6.6)
Net Income 22.5 43.1 60.7 45.2 68.9 (23.8) 14.1 10.8 25.8 (9.3)
EPS (Diluted) 0.46 0.90 1.29 0.99 1.52 1.01 0.39 0.29 0.90 -1.79
Balance Sheet
Cash & Equivalents 429.5 288.5 293.8 288.0 233.1 193.5 103.2 106.9 119.8 9.3
Total Assets 2,218.7 1,354.9 933.4 966.2 867.4 817.5 728.7 513.0 490.6 19.6
Total Debt 1,078.1 471.8 321.0 229.4 201.0 260.6 256.6 13.7 6.3 0.2
Stockholders' Equity 779.3 712.7 614.2 542.6 448.2 330.8 191.5 180.5 159.9 5.8
Cash Flow
Operating Cash Flow 114.6 52.2 68.2 82.1 70.3 46.2 13.7 26.1 53.1 (1.8)
Capital Expenditure (10.1) (8.0) (28.5) (22.9) (19.2) (1.2) (1.0) (1.2) (2.1) (0.3)
Free Cash Flow 104.5 44.2 39.7 59.2 51.1 45.0 12.6 24.9 51.0 (2.1)